您当前的位置:
首页 >
文章列表页 >
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
- “在癌症免疫治疗领域,研究人员总结了导致肿瘤微环境中T细胞耗竭的表观遗传学机制,并讨论了靶向表观遗传学调节因子用于免疫治疗的治疗潜力。这为构建涉及免疫刺激剂和表观遗传疗法的治疗范式奠定了基础。”
- MMR 2024年11卷第6期 页码:863-886
DOI: 10.1186/s40779-023-00496-2
移动端阅览
AI导读
HTML全文
图( 4 ) 表( 1 )
参考文献
出版信息
数据统计
28
浏览量
38
下载量
0
CSCD
文章被引用时,请邮件提醒。
提交
工具集
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
相关文章
Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
相关作者
暂无数据
相关机构
暂无数据

